Reported Standalone quarterly numbers for SOLARA ACTIVE PHARMA SCIENCES are: Net Sales at Rs 349.00 crore in December 2025 up ...
Board Meeting Outcome for Board Meeting Outcome For Unaudited Financial Results For The Quarter Ended December 31, 2025 - ...
Sales rise 16.21% to Rs 349.00 crore. Net loss of Solara Active Pharma Sciences reported to Rs 17.43 crore in the quarter ended December 2025 as against net profit of Rs 8.09 cror ...
Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter Ended December 31, 2025. - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools ...